메뉴 건너뛰기




Volumn 9, Issue , 2010, Pages

Renal protection in diabetes: Lessons from ONTARGET®

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; ENALAPRIL; GLICLAZIDE; INDAPAMIDE PLUS PERINDOPRIL; IRBESARTAN; LOSARTAN; OLMESARTAN; RAMIPRIL; TELMISARTAN; VALSARTAN; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 77957203809     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-60     Document Type: Review
Times cited : (31)

References (75)
  • 2
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • 10.1056/NEJM200001203420301, 10639539, The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G, . The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145-53. 10.1056/NEJM200001203420301, 10639539, The Heart Outcomes Prevention Evaluation Study Investigators.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 3
    • 48649105160 scopus 로고    scopus 로고
    • Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
    • 10.1016/S0140-6736(08)61193-9, 18757085, Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND®) Investigators
    • Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, . Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND®) Investigators Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008, 372:1174-83. 10.1016/S0140-6736(08)61193-9, 18757085, Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND®) Investigators.
    • (2008) Lancet , vol.372 , pp. 1174-1183
    • Yusuf, S.1    Teo, K.2    Anderson, C.3    Pogue, J.4    Dyal, L.5    Copland, I.6    Schumacher, H.7    Dagenais, G.8    Sleight, P.9
  • 5
    • 49149087718 scopus 로고    scopus 로고
    • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET® study): a multicentre, randomised, double-blind, controlled trial
    • 10.1016/S0140-6736(08)61236-2, 18707986, The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET®) Investigators
    • Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, . The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET®) Investigators Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET® study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008, 372:547-53. 10.1016/S0140-6736(08)61236-2, 18707986, The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET®) Investigators.
    • (2008) Lancet , vol.372 , pp. 547-553
    • Mann, J.F.1    Schmieder, R.E.2    McQueen, M.3    Dyal, L.4    Schumacher, H.5    Pogue, J.6    Wang, X.7    Maggioni, A.8    Budaj, A.9    Chaithiraphan, S.10    Dickstein, K.11    Keltai, M.12    Metsärinne, K.13    Oto, A.14    Parkhomenko, A.15    Piegas, L.S.16    Svendsen, T.L.17    Teo, K.K.18    Yusuf, S.19
  • 6
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation
    • Modification of Diet in Renal Disease Study Group
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, . Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-70. Modification of Diet in Renal Disease Study Group.
    • (1999) Ann Intern Med , vol.130 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 7
    • 33744958852 scopus 로고    scopus 로고
    • Assessing kidney function--measured and estimated glomerular filtration rate
    • 10.1056/NEJMra054415, 16760447
    • Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-83. 10.1056/NEJMra054415, 16760447.
    • (2006) N Engl J Med , vol.354 , pp. 2473-2483
    • Stevens, L.A.1    Coresh, J.2    Greene, T.3    Levey, A.S.4
  • 10
    • 27444435483 scopus 로고    scopus 로고
    • Screening techniques for detecting chronic kidney disease
    • 10.1097/01.mnh.0000183948.13739.ee, 16205477
    • de Jong PE, Gansevoort RT. Screening techniques for detecting chronic kidney disease. Curr Opin Nephrol Hypertens 2005, 14:567-72. 10.1097/01.mnh.0000183948.13739.ee, 16205477.
    • (2005) Curr Opin Nephrol Hypertens , vol.14 , pp. 567-572
    • de Jong, P.E.1    Gansevoort, R.T.2
  • 11
    • 1042302788 scopus 로고    scopus 로고
    • Nephropathy in diabetes
    • American Diabetes Association
    • American Diabetes Association Nephropathy in diabetes. Diabetes Care 2004, 27(Suppl 1):S79-S83. American Diabetes Association.
    • (2004) Diabetes Care , vol.27 , Issue.SUPPL 1
  • 12
    • 67650451498 scopus 로고    scopus 로고
    • Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration
    • 10.1053/j.ajkd.2009.04.029, 19577347
    • Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T. Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009, 54:205-226. 10.1053/j.ajkd.2009.04.029, 19577347.
    • (2009) Am J Kidney Dis , vol.54 , pp. 205-226
    • Levey, A.S.1    Cattran, D.2    Friedman, A.3    Miller, W.G.4    Sedor, J.5    Tuttle, K.6    Kasiske, B.7    Hostetter, T.8
  • 13
    • 65349131482 scopus 로고    scopus 로고
    • Prevalence of albuminuria and renal insufficiency in type 2 diabetes: the Japanese Diabetes Clinical Data Management study (JDDM15)
    • 10.1093/ndt/gfn603, 18984626, Japan Diabetes Clinical Data Management Study Group
    • Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, . Japan Diabetes Clinical Data Management Study Group Prevalence of albuminuria and renal insufficiency in type 2 diabetes: the Japanese Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009, 24:1212-19. 10.1093/ndt/gfn603, 18984626, Japan Diabetes Clinical Data Management Study Group.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1212-1219
    • Yokoyama, H.1    Sone, H.2    Oishi, M.3    Kawai, K.4    Fukumoto, Y.5    Kobayashi, M.6
  • 14
    • 0037378449 scopus 로고    scopus 로고
    • Proteinuria and the risk of developing end-stage renal disease
    • 10.1046/j.1523-1755.2003.00868.x, 12631363
    • Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003, 63:1468-74. 10.1046/j.1523-1755.2003.00868.x, 12631363.
    • (2003) Kidney Int , vol.63 , pp. 1468-1474
    • Iseki, K.1    Ikemiya, Y.2    Iseki, C.3    Takishita, S.4
  • 15
    • 33745318050 scopus 로고    scopus 로고
    • Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial
    • 10.1136/bmj.38814.566019.2F, 1479622, 16714328, Cholesterol and Recurrent Events (CARE) Trial Investigators
    • Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, . Cholesterol and Recurrent Events (CARE) Trial Investigators Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006, 332:1426. 10.1136/bmj.38814.566019.2F, 1479622, 16714328, Cholesterol and Recurrent Events (CARE) Trial Investigators.
    • (2006) BMJ , vol.332 , pp. 1426
    • Tonelli, M.1    Jose, P.2    Curhan, G.3    Sacks, F.4    Braunwald, E.5    Pfeffer, M.6
  • 16
    • 0037213037 scopus 로고    scopus 로고
    • Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)
    • 10.1046/j.1523-1755.2003.00712.x, 12472787, UKPDS GROUP
    • Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, . UKPDS GROUP Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003, 63:225-32. 10.1046/j.1523-1755.2003.00712.x, 12472787, UKPDS GROUP.
    • (2003) Kidney Int , vol.63 , pp. 225-232
    • Adler, A.I.1    Stevens, R.J.2    Manley, S.E.3    Bilous, R.W.4    Cull, C.A.5    Holman, R.R.6
  • 17
    • 1642413198 scopus 로고    scopus 로고
    • Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
    • 10.1001/archinte.164.6.659, 15037495
    • Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004, 164:659-63. 10.1001/archinte.164.6.659, 15037495.
    • (2004) Arch Intern Med , vol.164 , pp. 659-663
    • Keith, D.S.1    Nichols, G.A.2    Gullion, C.M.3    Brown, J.B.4    Smith, D.H.5
  • 18
    • 45849099504 scopus 로고    scopus 로고
    • Comorbidities in UK patients at the start of renal replacement therapy
    • 10.1093/ndt/gfm330, 17724052
    • Tomson C, Udayaraj U, Gilg J, Ansell D. Comorbidities in UK patients at the start of renal replacement therapy. Nephrol Dial Transplant 2007, 22(Suppl 7):vii58-vii68. 10.1093/ndt/gfm330, 17724052.
    • (2007) Nephrol Dial Transplant , vol.22 , Issue.SUPPL 7
    • Tomson, C.1    Udayaraj, U.2    Gilg, J.3    Ansell, D.4
  • 19
    • 0032916219 scopus 로고    scopus 로고
    • Cardiovascular mortality and morbidity in dialysis patients
    • 10.1159/000057429, 10207269
    • Eknoyan G. Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab 1999, 25:100-104. 10.1159/000057429, 10207269.
    • (1999) Miner Electrolyte Metab , vol.25 , pp. 100-104
    • Eknoyan, G.1
  • 20
    • 0035901585 scopus 로고    scopus 로고
    • Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial
    • Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001, 134:629-36.
    • (2001) Ann Intern Med , vol.134 , pp. 629-636
    • Mann, J.F.1    Gerstein, H.C.2    Pogue, J.3    Bosch, J.4    Yusuf, S.5
  • 21
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
    • 10.1016/S0140-6736(07)61303-8, 17765963, ADVANCE Collaborative Group
    • Patel A, . ADVANCE Collaborative Group Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829-40. 10.1016/S0140-6736(07)61303-8, 17765963, ADVANCE Collaborative Group.
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1
  • 23
    • 34347254676 scopus 로고    scopus 로고
    • The Framingham Risk Score: an appraisal of its benefits and limitations
    • 10.1111/j.1541-9215.2007.06350.x, 17478974
    • Hemann BA, Bimson WF, Taylor AJ. The Framingham Risk Score: an appraisal of its benefits and limitations. Am Heart Hosp J 2007, 5:91-96. 10.1111/j.1541-9215.2007.06350.x, 17478974.
    • (2007) Am Heart Hosp J , vol.5 , pp. 91-96
    • Hemann, B.A.1    Bimson, W.F.2    Taylor, A.J.3
  • 24
    • 0034837376 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality associated with the metabolic syndrome
    • 10.2337/diacare.24.4.683, 11315831
    • Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-89. 10.2337/diacare.24.4.683, 11315831.
    • (2001) Diabetes Care , vol.24 , pp. 683-689
    • Isomaa, B.1    Almgren, P.2    Tuomi, T.3    Forsén, B.4    Lahti, K.5    Nissén, M.6    Taskinen, M.R.7    Groop, L.8
  • 25
    • 0037334224 scopus 로고    scopus 로고
    • Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
    • 10.1016/S0140-6736(03)12655-4, 12620735
    • Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003, 361:717-25. 10.1016/S0140-6736(03)12655-4, 12620735.
    • (2003) Lancet , vol.361 , pp. 717-725
    • Murray, C.J.1    Lauer, J.A.2    Hutubessy, R.C.3    Niessen, L.4    Tomijima, N.5    Rodgers, A.6    Lawes, C.M.7    Evans, D.B.8
  • 26
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266. National Kidney Foundation.
    • (2002) Am J Kidney Dis , vol.39 , Issue.2 SUPPL 1
  • 27
    • 0042830443 scopus 로고    scopus 로고
    • Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure
    • 10.1046/j.1365-2796.2003.01207.x, 12930230
    • Tryggvason K, Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med 2003, 254:216-24. 10.1046/j.1365-2796.2003.01207.x, 12930230.
    • (2003) J Intern Med , vol.254 , pp. 216-224
    • Tryggvason, K.1    Pettersson, E.2
  • 28
    • 33947226955 scopus 로고    scopus 로고
    • Cellular and molecular biology of membranous nephropathy
    • Couser WG, Nangaku M. Cellular and molecular biology of membranous nephropathy. J Nephrol 2006, 19:699-705.
    • (2006) J Nephrol , vol.19 , pp. 699-705
    • Couser, W.G.1    Nangaku, M.2
  • 29
    • 23044501315 scopus 로고    scopus 로고
    • Endothelial dysfunction is correlated with microalbuminuria in children with short-duration type 1 diabetes
    • 10.2337/diacare.28.8.2048, 16043758
    • Ladeia AM, Ladeia-Frota C, Pinho L, Stefanelli E, Adan L. Endothelial dysfunction is correlated with microalbuminuria in children with short-duration type 1 diabetes. Diabetes Care 2005, 28:2048-50. 10.2337/diacare.28.8.2048, 16043758.
    • (2005) Diabetes Care , vol.28 , pp. 2048-2050
    • Ladeia, A.M.1    Ladeia-Frota, C.2    Pinho, L.3    Stefanelli, E.4    Adan, L.5
  • 30
    • 77952109980 scopus 로고    scopus 로고
    • The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study
    • 10.1186/1475-2840-9-18, 2877657, 20470427
    • Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 2010, 9:18. 10.1186/1475-2840-9-18, 2877657, 20470427.
    • (2010) Cardiovasc Diabetol , vol.9 , pp. 18
    • Ito, H.1    Komatsu, Y.2    Mifune, M.3    Antoku, S.4    Ishida, H.5    Takeuchi, Y.6    Togane, M.7
  • 31
    • 0031788869 scopus 로고    scopus 로고
    • Mechanism of progression of renal disease: current hemodynamic concepts
    • 10.1097/00004872-199816010-00002, 9817185
    • Johnston CI, Risvanis J, Naitoh M, Tikkanen I. Mechanism of progression of renal disease: current hemodynamic concepts. J Hypertens Suppl 1998, 16:S3-S7. 10.1097/00004872-199816010-00002, 9817185.
    • (1998) J Hypertens Suppl , vol.16
    • Johnston, C.I.1    Risvanis, J.2    Naitoh, M.3    Tikkanen, I.4
  • 32
    • 0033007050 scopus 로고    scopus 로고
    • The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus
    • 10.1007/s001250051189, 10333042
    • Fagerudd JA, Pettersson-Fernholm KJ, Gronhagen-Riska C, Groop PH. The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:519-26. 10.1007/s001250051189, 10333042.
    • (1999) Diabetologia , vol.42 , pp. 519-526
    • Fagerudd, J.A.1    Pettersson-Fernholm, K.J.2    Gronhagen-Riska, C.3    Groop, P.H.4
  • 33
    • 0242383894 scopus 로고    scopus 로고
    • Lifestyle risk factors and chronic kidney disease
    • 10.1016/S1047-2797(03)00066-8, 14599736
    • Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 2003, 13:712-20. 10.1016/S1047-2797(03)00066-8, 14599736.
    • (2003) Ann Epidemiol , vol.13 , pp. 712-720
    • Vupputuri, S.1    Sandler, D.P.2
  • 34
    • 33644790793 scopus 로고    scopus 로고
    • Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation
    • 10.1681/ASN.2004090783, 15987756, Dutch POPS-19 Collaborative Study Group
    • Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frölich M, van der Heijden BJ, . Dutch POPS-19 Collaborative Study Group Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 2005, 16:2762-68. 10.1681/ASN.2004090783, 15987756, Dutch POPS-19 Collaborative Study Group.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2762-2768
    • Keijzer-Veen, M.G.1    Schrevel, M.2    Finken, M.J.3    Dekker, F.W.4    Nauta, J.5    Hille, E.T.6    Frölich, M.7    van der Heijden, B.J.8
  • 36
    • 38149131097 scopus 로고    scopus 로고
    • Low birth weight increases risk for end-stage renal disease
    • 10.1681/ASN.2007020252, 2391041, 18057216
    • Vikse BE, Irgens LM, Leivestad T, Hallan S, Iversen BM. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008, 19:151-57. 10.1681/ASN.2007020252, 2391041, 18057216.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 151-157
    • Vikse, B.E.1    Irgens, L.M.2    Leivestad, T.3    Hallan, S.4    Iversen, B.M.5
  • 37
    • 27744594622 scopus 로고    scopus 로고
    • Long-term consequences of low birth weight
    • 10.1111/j.1523-1755.2005.09718.x, 16014086
    • Reyes L, Manalich R. Long-term consequences of low birth weight. Kidney Int Suppl 2005, (Suppl):S107-S111. 10.1111/j.1523-1755.2005.09718.x, 16014086.
    • (2005) Kidney Int Suppl , Issue.SUPPL
    • Reyes, L.1    Manalich, R.2
  • 38
    • 49649119083 scopus 로고    scopus 로고
    • Evidence of arteriolar narrowing in low-birth-weight children
    • 10.1161/CIRCULATIONAHA.107.747329, 18625895
    • Mitchell P, Liew G, Rochtchina E, Wang JJ, Robaei D, Cheung N, Wong TY. Evidence of arteriolar narrowing in low-birth-weight children. Circulation 2008, 118:518-24. 10.1161/CIRCULATIONAHA.107.747329, 18625895.
    • (2008) Circulation , vol.118 , pp. 518-524
    • Mitchell, P.1    Liew, G.2    Rochtchina, E.3    Wang, J.J.4    Robaei, D.5    Cheung, N.6    Wong, T.Y.7
  • 39
    • 42049114695 scopus 로고    scopus 로고
    • Low birthweight is associated with narrower arterioles in adults
    • 10.1161/HYPERTENSIONAHA.107.101584, 18268137, Atherosclerosis Risk in Communities Study
    • Liew G, Wang JJ, Duncan BB, Klein R, Sharrett AR, Brancati F, Yeh HC, Mitchell P, Wong TY, . Atherosclerosis Risk in Communities Study Low birthweight is associated with narrower arterioles in adults. Hypertension 2008, 51:933-38. 10.1161/HYPERTENSIONAHA.107.101584, 18268137, Atherosclerosis Risk in Communities Study.
    • (2008) Hypertension , vol.51 , pp. 933-938
    • Liew, G.1    Wang, J.J.2    Duncan, B.B.3    Klein, R.4    Sharrett, A.R.5    Brancati, F.6    Yeh, H.C.7    Mitchell, P.8    Wong, T.Y.9
  • 40
    • 0034732256 scopus 로고    scopus 로고
    • Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study
    • 10.1056/NEJM200003303421301, 10738048
    • Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000, 342:905-12. 10.1056/NEJM200003303421301, 10738048.
    • (2000) N Engl J Med , vol.342 , pp. 905-912
    • Gress, T.W.1    Nieto, F.J.2    Shahar, E.3    Wofford, M.R.4    Brancati, F.L.5
  • 41
    • 17644378057 scopus 로고    scopus 로고
    • Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease
    • 10.1001/archinte.165.8.923, 15851645
    • Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005, 165:923-28. 10.1001/archinte.165.8.923, 15851645.
    • (2005) Arch Intern Med , vol.165 , pp. 923-928
    • Hsu, C.Y.1    McCulloch, C.E.2    Darbinian, J.3    Go, A.S.4    Iribarren, C.5
  • 42
    • 0014456533 scopus 로고
    • The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels
    • Keen H, Chlouverakis C, Fuller J, Jarrett RJ. The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep 1969, 118:247-54.
    • (1969) Guys Hosp Rep , vol.118 , pp. 247-254
    • Keen, H.1    Chlouverakis, C.2    Fuller, J.3    Jarrett, R.J.4
  • 43
    • 0038188642 scopus 로고    scopus 로고
    • Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy
    • 10.1046/j.1523-1755.2003.00007.x, 12753303
    • Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO. Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 2003, 63:2162-70. 10.1046/j.1523-1755.2003.00007.x, 12753303.
    • (2003) Kidney Int , vol.63 , pp. 2162-2170
    • Janssen, U.1    Riley, S.G.2    Vassiliadou, A.3    Floege, J.4    Phillips, A.O.5
  • 44
    • 0028215329 scopus 로고
    • The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group
    • 10.1056/NEJM199403313301301, 8114857
    • Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994, 330:877-84. 10.1056/NEJM199403313301301, 8114857.
    • (1994) N Engl J Med , vol.330 , pp. 877-884
    • Klahr, S.1    Levey, A.S.2    Beck, G.J.3    Caggiula, A.W.4    Hunsicker, L.5    Kusek, J.W.6    Striker, G.7
  • 45
    • 14344255910 scopus 로고    scopus 로고
    • The effect of lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study
    • Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS. The effect of lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease Study. Ann Intern Med 2005, 142:342-51.
    • (2005) Ann Intern Med , vol.142 , pp. 342-351
    • Sarnak, M.J.1    Greene, T.2    Wang, X.3    Beck, G.4    Kusek, J.W.5    Collins, A.J.6    Levey, A.S.7
  • 46
    • 0036190137 scopus 로고    scopus 로고
    • Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
    • 10.1046/j.1523-1755.2002.00213.x, 11849464
    • Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002, 61:1086-97. 10.1046/j.1523-1755.2002.00213.x, 11849464.
    • (2002) Kidney Int , vol.61 , pp. 1086-1097
    • Schrier, R.W.1    Estacio, R.O.2    Esler, A.3    Mehler, P.4
  • 49
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • 10.1056/NEJMoa011303, 11565517, Collaborative Study Group
    • Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, . Collaborative Study Group Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851-60. 10.1056/NEJMoa011303, 11565517, Collaborative Study Group.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3    Berl, T.4    Pohl, M.A.5    Lewis, J.B.6    Ritz, E.7    Atkins, R.C.8    Rohde, R.9    Raz, I.10
  • 50
    • 77951735232 scopus 로고    scopus 로고
    • Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
    • The ACCORD Study Group
    • The ACCORD Study Group Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010, 17:1575-85. The ACCORD Study Group.
    • (2010) N Engl J Med , vol.17 , pp. 1575-1585
  • 52
    • 33646156403 scopus 로고    scopus 로고
    • Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure
    • 10.1161/01.HYP.0000215363.69793.bb, 16567588
    • Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006, 47:846-53. 10.1161/01.HYP.0000215363.69793.bb, 16567588.
    • (2006) Hypertension , vol.47 , pp. 846-853
    • Mancia, G.1    Facchetti, R.2    Bombelli, M.3    Grassi, G.4    Sega, R.5
  • 53
    • 33646137566 scopus 로고    scopus 로고
    • Office and ambulatory blood pressure are independently associated with albuminuria in older subjects with type 2 diabetes
    • 10.1161/01.HYP.0000216634.73504.7d, 16585416
    • Moran A, Palmas W, Pickering TG, Schwartz JE, Field L, Weinstock RS, Shea S. Office and ambulatory blood pressure are independently associated with albuminuria in older subjects with type 2 diabetes. Hypertension 2006, 47:955-61. 10.1161/01.HYP.0000216634.73504.7d, 16585416.
    • (2006) Hypertension , vol.47 , pp. 955-961
    • Moran, A.1    Palmas, W.2    Pickering, T.G.3    Schwartz, J.E.4    Field, L.5    Weinstock, R.S.6    Shea, S.7
  • 54
    • 27844568135 scopus 로고    scopus 로고
    • Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus
    • Gallego PH, Gilbey AJ, Grant MT, Bulsara MK, Byme GC, Jones TW, Frazer FL. Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005, 18:879-85.
    • (2005) J Pediatr Endocrinol Metab , vol.18 , pp. 879-885
    • Gallego, P.H.1    Gilbey, A.J.2    Grant, M.T.3    Bulsara, M.K.4    Byme, G.C.5    Jones, T.W.6    Frazer, F.L.7
  • 55
    • 40049112460 scopus 로고    scopus 로고
    • Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes
    • 10.1111/j.1524-6175.2007.07170.x, 18174766
    • Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, Weinstock RS, Shea S. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich) 2008, 10:12-20. 10.1111/j.1524-6175.2007.07170.x, 18174766.
    • (2008) J Clin Hypertens (Greenwich) , vol.10 , pp. 12-20
    • Palmas, W.1    Pickering, T.2    Teresi, J.3    Schwartz, J.E.4    Eguchi, K.5    Field, L.6    Weinstock, R.S.7    Shea, S.8
  • 56
    • 18844449196 scopus 로고    scopus 로고
    • Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes
    • 10.1097/01.hjh.0000160198.05416.72, 15716683
    • Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005, 23:463-73. 10.1097/01.hjh.0000160198.05416.72, 15716683.
    • (2005) J Hypertens , vol.23 , pp. 463-473
    • Jandeleit-Dahm, K.A.1    Tikellis, C.2    Reid, C.M.3    Johnston, C.I.4    Cooper, M.E.5
  • 57
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • 10.1056/NEJMoa011161, 11565518, RENAAL Study Investigators
    • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, . RENAAL Study Investigators Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861-69. 10.1056/NEJMoa011161, 11565518, RENAAL Study Investigators.
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    de Zeeuw, D.3    Keane, W.F.4    Mitch, W.E.5    Parving, H.H.6    Remuzzi, G.7    Snapinn, S.M.8    Zhang, Z.9    Shahinfar, S.10
  • 61
    • 8144224441 scopus 로고    scopus 로고
    • Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
    • 10.1161/01.CIR.0000146378.65439.7A, 15492322
    • Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH. Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004, 110:2809-16. 10.1161/01.CIR.0000146378.65439.7A, 15492322.
    • (2004) Circulation , vol.110 , pp. 2809-2816
    • Asselbergs, F.W.1    Diercks, G.F.2    Hillege, H.L.3    van Boven, A.J.4    Janssen, W.M.5    Voors, A.A.6    de Zeeuw, D.7    de Jong, P.E.8    van Veldhuisen, D.J.9    van Gilst, W.H.10
  • 64
    • 0041332950 scopus 로고    scopus 로고
    • The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) programme
    • Weber M. The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) programme. J Hypertens 2003, 21(Suppl 6):S37-S46.
    • (2003) J Hypertens , vol.21 , Issue.SUPPL 6
    • Weber, M.1
  • 65
    • 34249869003 scopus 로고    scopus 로고
    • Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes
    • 10.2337/dc06-1551, 17337492
    • Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care 2007, 30:1351-56. 10.2337/dc06-1551, 17337492.
    • (2007) Diabetes Care , vol.30 , pp. 1351-1356
    • Schmieder, R.E.1    Delles, C.2    Mimran, A.3    Fauvel, J.P.4    Ruilope, L.M.5
  • 66
    • 34249899918 scopus 로고    scopus 로고
    • Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes
    • 10.2337/dc06-1998, 17389334, INNOVATION Study Group
    • Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S, . INNOVATION Study Group Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care 2007, 30:1577-78. 10.2337/dc06-1998, 17389334, INNOVATION Study Group.
    • (2007) Diabetes Care , vol.30 , pp. 1577-1578
    • Makino, H.1    Haneda, M.2    Babazono, T.3    Moriya, T.4    Ito, S.5    Iwamoto, Y.6    Kawamori, R.7    Takeuchi, M.8    Katayama, S.9
  • 67
    • 7444237666 scopus 로고    scopus 로고
    • Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
    • 10.1056/NEJMoa042274, 15516696, Diabetics Exposed to Telmisartan and Enalapril Study Group
    • Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J, . Diabetics Exposed to Telmisartan and Enalapril Study Group Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004, 351:1952-61. 10.1056/NEJMoa042274, 15516696, Diabetics Exposed to Telmisartan and Enalapril Study Group.
    • (2004) N Engl J Med , vol.351 , pp. 1952-1961
    • Barnett, A.H.1    Bain, S.C.2    Bouter, P.3    Karlberg, B.4    Madsbad, S.5    Jervell, J.6    Mustonen, J.7
  • 68
    • 18744395241 scopus 로고    scopus 로고
    • Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL®) study
    • 10.1007/s00592-005-0180-4, 15868119
    • Barnett AH. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL®) study. Acta Diabetol 2005, 42(Suppl 1):S42-S49. 10.1007/s00592-005-0180-4, 15868119.
    • (2005) Acta Diabetol , vol.42 , Issue.SUPPL 1
    • Barnett, A.H.1
  • 69
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • 10.1056/NEJMoa011489, 11565519, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
    • Parving HH, Lehnert H, Broechner-Mortensen J, Gomis R, Andersen S, Arner P, . Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-78. 10.1056/NEJMoa011489, 11565519, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group.
    • (2001) N Engl J Med , vol.345 , pp. 870-878
    • Parving, H.H.1    Lehnert, H.2    Broechner-Mortensen, J.3    Gomis, R.4    Andersen, S.5    Arner, P.6
  • 70
    • 48949118159 scopus 로고    scopus 로고
    • Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy
    • 10.1038/ki.2008.204, 18496508
    • Bakris G, Burgess E, Weir M, Davidai G, Koval S. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int 2008, 74:364-69. 10.1038/ki.2008.204, 18496508.
    • (2008) Kidney Int , vol.74 , pp. 364-369
    • Bakris, G.1    Burgess, E.2    Weir, M.3    Davidai, G.4    Koval, S.5
  • 71
    • 52649110647 scopus 로고    scopus 로고
    • Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy
    • 10.1093/ndt/gfn230, 18450829
    • Galle J, Schwedhelm E, Pinnetti S, Boger RH, Wanner C. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy. Nephrol Dial Transplant 2008, 23:3174-83. 10.1093/ndt/gfn230, 18450829.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 3174-3183
    • Galle, J.1    Schwedhelm, E.2    Pinnetti, S.3    Boger, R.H.4    Wanner, C.5
  • 72
    • 0030905088 scopus 로고    scopus 로고
    • Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population
    • Baracskay D, Jarjoura D, Cugino A, Blend D, Rutecki GW, Whittier FC. Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population. Clin Nephrol 1997, 47:222-28.
    • (1997) Clin Nephrol , vol.47 , pp. 222-228
    • Baracskay, D.1    Jarjoura, D.2    Cugino, A.3    Blend, D.4    Rutecki, G.W.5    Whittier, F.C.6
  • 74
    • 1442348810 scopus 로고    scopus 로고
    • Implementation of guidelines for the prevention of diabetic nephropathy
    • 10.2337/diacare.27.3.803, 14988308
    • Fagerudd J, Forsblom C, Pettersson-Fernholm K, Groop PH. Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care 2004, 27:803-804. 10.2337/diacare.27.3.803, 14988308.
    • (2004) Diabetes Care , vol.27 , pp. 803-804
    • Fagerudd, J.1    Forsblom, C.2    Pettersson-Fernholm, K.3    Groop, P.H.4
  • 75
    • 33746764463 scopus 로고    scopus 로고
    • Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings
    • 10.1097/01.hjh.0000239303.93872.31, 16877970
    • Minutolo R, Sasso FC, Chiodini P, Cianciaruso B, Carbonara O, Zamboli P, Tirino G, Pota A, Torella R, Conte G, De Nicola L. Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. J Hypertens 2006, 24:1655-61. 10.1097/01.hjh.0000239303.93872.31, 16877970.
    • (2006) J Hypertens , vol.24 , pp. 1655-1661
    • Minutolo, R.1    Sasso, F.C.2    Chiodini, P.3    Cianciaruso, B.4    Carbonara, O.5    Zamboli, P.6    Tirino, G.7    Pota, A.8    Torella, R.9    Conte, G.10    De Nicola, L.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.